Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
- Cycloset
- Cycloset Clinical Profile
- Mechanism of Action
- Pre-Clinical Studies
- Clinical Studies
- U.S. Cycloset Patents
- Visit www.cycloset.com for
more information on the product

